Do GLP-1 Injections Make You Feel Tired?
US$ 23.93
abbvie glp-1 receptor agonists weight management diabetes treatments Evolution of GLP‐1 for Treatment Drugmakers are racing to find
Description
Over the 20th century, additional treatments were developed and FDA approved for treatment of overweight and obesity, including phentermine, phentermine/topiramate, orlistat, and naltrexone/bupropion
doi: 10.1186/s12933-023-01877-6
In 2021, semaglutide under the name Wegovy was approved for weight loss
Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias
(3) development of next-generation GLP-1 receptor-targeted therapeutics with enhanced specificity and reduced off-target effects [129,130,131,132]
PMID: 36629465
